In current study, we first revealed that IGF2-AS was significantly down-regulated in the HCC patient tissues than in the normal control tissues based on the high-throughput RNA-seq data from both the TCGA database and the GEPIA database. This evidence concerns the gene IGF2 and hepatocellular carcinoma.